News Release

Mexico distribution agreement signed

Date: 1999/04/15

International Wex Technologies Inc.(the Company) is pleased to announce that they have capitalized on the letter of intent with Angel Investments Ltd. as outlined in our December 18, 1998 news release. The Company has entered into an exclusive distribution agreement with an entity newly incorporated in British Columbia by Angel Investments Ltd. d.b.a. Lifeline Pharmacorp, which will commence retailing the Company’s proprietary product Tetrodin (HT) in Mexico.

Lifeline Pharmacorp will be marketing Tetrodin (HT) to North America from Mexican clinics and hospitals.

Lifeline Pharmacorp expects ultimately to require 50 employees, the services of 10 physicians, and projects annual gross revenue in excess of US$70 million .

Lifeline Pharmacorp is presently securing the necessary import documentation for Tetrodin (HT) into Mexico. The Company will receive an opening order of US$120,000.00 once the import permit has been issued.

Mr. R.A. (Bob) Bedard, the president of Lifeline Pharmacorp may be reached at (604) 725-3088 for any further information on Lifeline Pharmacorp.

International Wex Technologies Inc. will enjoy revenues as both a manufacturer and supplier of Tetrodin(HT), as well as a 20% shareholder in Lifeline Pharmacorp.

Tetrodin (HT) is a patented non-narcotic withdrawal treatment for Heroin and all other opiates addictions.

For additional information on Tetrodin (HT), view the IWT website at http://www.wextech.ca or call Howard Milne at 604-683-8880 or 1-800-722-7549.

Per: Donna Shum, Corporate Secretary